Bliss GVS Pharma Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹225.68Cr |
Net Profits | ₹23.80Cr |
Net Profit Margins | 10.55% |
Highlights
Revenue:
Bliss GVS Pharma Ltd’s revenue jumped 9.48% since last year same period to ₹225.68Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated 1.33% jump in its revenue since last 3-months.
Net Profits:
Bliss GVS Pharma Ltd’s net profit fell -13.8% since last year same period to ₹23.80Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -1.9% fall in its net profits since last 3-months.
Net Profit Margins:
Bliss GVS Pharma Ltd’s net profit margin fell -21.26% since last year same period to 10.55% in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -3.18% fall in its net profit margins since last 3-months.
